References
- Tarakad A, Jankovic J. Diagnosis and management of Parkinson’s disease. Semin Neurol. 2017;37(02):118–126.
- Lee E-Y, Sen S, Eslinger PJ, et al. Side of motor onset is associated with hemisphere-specific memory decline and lateralized gray matter loss in Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(5):465–470.
- Wishart S, Macphee GJA. Evaluation and management of the non-motor features of Parkinson’s disease. Ther Adv Chron Dis. 2011;2(2):69–85.
- Ortuño-Lizarán I, Beach TG, Serrano GE, et al. α-Synuclein in the retina is a biomarker of Parkinson’s disease pathology severity. Mov Disord. 2018;33(8):1315–1324.
- Weil RS, Schrag AE, Warren JD, et al. Visual dysfunction in Parkinson’s disease. Brain. 2016;139(11):2827–2843.
- Antonia I, Sonka K, Dušek P. Olfaction and colour vision: what can they tell us about Parkinson’s disease? Prague Med Rep. 2018;119:85–96.
- Biousse V, Skibell BC, Watts RL, et al. Ophthalmologic features of Parkinson’s disease. Neurology. 2004;62(2):177–180.
- Clark D, Eggenberger E. Neuro-ophthalmology of movement disorders. Curr Opin Ophthalmol. 2012;23(6):491–496.
- Demirci S, Gunes A, Koyuncuoglu HR, et al. Evaluation of corneal parameters in patients with Parkinson’s disease. Neurol Sci. 2016;37(8):1247–1252.
- Liu Z, Pflugfelder SC. Corneal thickness is reduced in dry eye. Cornea. 1999;18:403–407.
- Ambrosio R Jr, Alonso RS, Luz A. Coca Velarde LG. Corneal-thickness spatial profile and corneal-volume distribution: tomographic indices to detect keratoconus. J Cataract Refract Surg. 2006;32:1851–1859.
- Gabriele ML, Wollstein G, Ishikawa H, et al. Optical coherence tomography: history, current status, and laboratory work. Invest Ophthalmol Vis Sci. 2011;52(5):2425–2436.
- Francoz M, Karamoko I, Baudouin C, et al. Ocular surface epithelial thickness evaluation with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2011;52(12):9116–9123.
- Shapiro BL, Cortés DE, Chin EK, et al. High-resolution spectral domain anterior segment optical coherence tomography in type 1 Boston keratoprosthesis. Cornea. 2013;32(7):951–955.
- Litvan I, Bhatia KP, Burn DJ, et al. Movement disorders society scientific issues committee. Movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord. 2003;18(5):467–486.
- Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427–442.
- Ang M, Baskaran M, Werkmeister RM, et al. Anterior segment optical coherence tomography. Prog Retin Eye Res. 2018;66:132–156.
- Huang F, Tseng S, Shih M, et al. Effect of artificial tears on corneal surface regularity, contrast sensitivity, and glare disability in dry eyes. Ophthalmology. 2002;109(10):1934–1940.
- Agostino R, Bologna M, Dinapoli L, et al. Voluntary, spontaneous, and reflex blinking in Parkinson’s disease. Mov Disord. 2008;23(5):669–675.
- Karson CN, Le Witt PA, Calne DB, et al. Blink rates in parkinsonism. Ann Neurol. 1982;12(6):580–583.
- Fitzpatrick E, Hohl N, Silburn P, et al. Case-control study of blink rate in Parkinson’s disease under different conditions. J Neurol. 2012;259(4):739–744.
- Tamer C, Melek IM, Duman T, et al. Tear film tests in Parkinson’s disease patients. Ophthalmology. 2005;112(10):1795.e1–1795.e8.
- Çomoğlu SS, Güven H, Acar M, et al. Tear levels of tumor necrosis factor-alpha in patients with Parkinson’s disease. Neurosci Lett. 2013;553:63–67.
- Reddy VC, Patel SV, Hodge DO, et al. Corneal sensitivity, blink rate, and corneal nerve density in progressive supranuclear palsy and Parkinson disease. Cornea. 2013;32:631–635.
- Aksoy D, Ortak H, Kurt S, et al. Central corneal thickness and its relationship to Parkinson’s disease severity. Can J Ophthalmol. 2014;49(2):152–156.
- Nowacka B, Lubinski W, Honczarenko K, et al. Ophthalmological features of Parkinson disease. Med Sci Monit. 2014;20:2243–2249.
- Bayer AU, Keller ON, Ferrari F, et al. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer’s disease and Parkinson’s disease. Am J Ophthalmol. 2002;133(1):135–137.
- Yenice O, Onal S, Midi I, et al. Visual field analysis is in patients with Parkinson’s disease. Parkinsonism Relat Disord. 2008;14(3):193–198.
- Medeiros FA, Sample PA, Zangwill LM, et al. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol. 2003;136(5):805–813.
- Shah S, Chatterjee A, Mathai M, et al. Relationship between corneal thickness and measured intraocular pressure in a general ophthalmology clinic. Ophthalmology. 1999;106(11):2154–2160.
- Guedes G, Tsai JC, Loewen NA. Glaucoma and aging. CAS. 2011;4(2):110–117.
- Karadayi K, Ciftci F, Akin T, et al. Increase in central corneal thickness in dry and normal eyes with application of artificial tears: a new diagnostic and follow-up criterion for dry eye. Oph Phys Opt. 2005;25(6):485–491.
- Chang KC, Jeong JH, Kim MK, et al. The effect of amantadine on corneal endothelium in subjects with Parkinson’s disease. Ophthalmology. 2010;117(6):1214–1219.